Short- vs. Long-Course Antibiotic Treatment for Acute Streptococcal Pharyngitis: Systematic Review and Meta-Analysis of Randomized Controlled Trials

Research output: Contribution to journalReviewResearchpeer-review

Standard

Short- vs. Long-Course Antibiotic Treatment for Acute Streptococcal Pharyngitis : Systematic Review and Meta-Analysis of Randomized Controlled Trials. / Holm, Anna Engell; Llor, Carl; Bjerrum, Lars; Cordoba, Gloria.

In: Antibiotics, Vol. 9, No. 11, 733, 2020.

Research output: Contribution to journalReviewResearchpeer-review

Harvard

Holm, AE, Llor, C, Bjerrum, L & Cordoba, G 2020, 'Short- vs. Long-Course Antibiotic Treatment for Acute Streptococcal Pharyngitis: Systematic Review and Meta-Analysis of Randomized Controlled Trials', Antibiotics, vol. 9, no. 11, 733. https://doi.org/10.3390/antibiotics9110733

APA

Holm, A. E., Llor, C., Bjerrum, L., & Cordoba, G. (2020). Short- vs. Long-Course Antibiotic Treatment for Acute Streptococcal Pharyngitis: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Antibiotics, 9(11), [733]. https://doi.org/10.3390/antibiotics9110733

Vancouver

Holm AE, Llor C, Bjerrum L, Cordoba G. Short- vs. Long-Course Antibiotic Treatment for Acute Streptococcal Pharyngitis: Systematic Review and Meta-Analysis of Randomized Controlled Trials. Antibiotics. 2020;9(11). 733. https://doi.org/10.3390/antibiotics9110733

Author

Holm, Anna Engell ; Llor, Carl ; Bjerrum, Lars ; Cordoba, Gloria. / Short- vs. Long-Course Antibiotic Treatment for Acute Streptococcal Pharyngitis : Systematic Review and Meta-Analysis of Randomized Controlled Trials. In: Antibiotics. 2020 ; Vol. 9, No. 11.

Bibtex

@article{fa23885a45344021bbc21cf44c003ba1,
title = "Short- vs. Long-Course Antibiotic Treatment for Acute Streptococcal Pharyngitis: Systematic Review and Meta-Analysis of Randomized Controlled Trials",
abstract = "BACKGROUND: To evaluate the effectiveness of short courses of antibiotic therapy for patients with acute streptococcal pharyngitis.METHODS: Randomized controlled trials comparing short-course antibiotic therapy (≤5 days) with long-course antibiotic therapy (≥7 days) for patients with streptococcal pharyngitis were included. Two primary outcomes: early clinical cure and early bacterial eradication.RESULTS: Fifty randomized clinical trials were included. Overall, short-course antibiotic treatment was as effective as long-course antibiotic treatment for early clinical cure (odds ratio (OR) 0.85; 95% confidence interval (CI) 0.79 to 1.15). Subgroup analysis showed that short-course penicillin was less effective for early clinical cure (OR 0.43; 95% CI, 0.23 to 0.82) and bacteriological eradication (OR 0.34; 95% CI, 0.19 to 0.61) in comparison to long-course penicillin. Short-course macrolides were equally effective, compared to long-course penicillin. Finally, short-course cephalosporin was more effective for early clinical cure (OR 1.48; 95% CI, 1.11 to 1.96) and early microbiological cure (OR 1.60; 95% CI, 1.13 to 2.27) in comparison to long-course penicillin. In total, 1211 (17.7%) participants assigned to short-course antibiotic therapy, and 893 (12.3%) cases assigned to long-course, developed adverse events (OR 1.35; 95% CI, 1.08 to 1.68).CONCLUSIONS: Macrolides and cephalosporins belong to the list of {"}Highest Priority Critically Important Antimicrobials{"}; hence, long-course penicillin V should remain as the first line antibiotic for the management of patients with streptococcal pharyngitis as far as the benefits of using these two types of antibiotics do not outweigh the harms of their unnecessary use.",
author = "Holm, {Anna Engell} and Carl Llor and Lars Bjerrum and Gloria Cordoba",
year = "2020",
doi = "10.3390/antibiotics9110733",
language = "English",
volume = "9",
journal = "Antibiotics",
issn = "2079-6382",
publisher = "M D P I AG",
number = "11",

}

RIS

TY - JOUR

T1 - Short- vs. Long-Course Antibiotic Treatment for Acute Streptococcal Pharyngitis

T2 - Systematic Review and Meta-Analysis of Randomized Controlled Trials

AU - Holm, Anna Engell

AU - Llor, Carl

AU - Bjerrum, Lars

AU - Cordoba, Gloria

PY - 2020

Y1 - 2020

N2 - BACKGROUND: To evaluate the effectiveness of short courses of antibiotic therapy for patients with acute streptococcal pharyngitis.METHODS: Randomized controlled trials comparing short-course antibiotic therapy (≤5 days) with long-course antibiotic therapy (≥7 days) for patients with streptococcal pharyngitis were included. Two primary outcomes: early clinical cure and early bacterial eradication.RESULTS: Fifty randomized clinical trials were included. Overall, short-course antibiotic treatment was as effective as long-course antibiotic treatment for early clinical cure (odds ratio (OR) 0.85; 95% confidence interval (CI) 0.79 to 1.15). Subgroup analysis showed that short-course penicillin was less effective for early clinical cure (OR 0.43; 95% CI, 0.23 to 0.82) and bacteriological eradication (OR 0.34; 95% CI, 0.19 to 0.61) in comparison to long-course penicillin. Short-course macrolides were equally effective, compared to long-course penicillin. Finally, short-course cephalosporin was more effective for early clinical cure (OR 1.48; 95% CI, 1.11 to 1.96) and early microbiological cure (OR 1.60; 95% CI, 1.13 to 2.27) in comparison to long-course penicillin. In total, 1211 (17.7%) participants assigned to short-course antibiotic therapy, and 893 (12.3%) cases assigned to long-course, developed adverse events (OR 1.35; 95% CI, 1.08 to 1.68).CONCLUSIONS: Macrolides and cephalosporins belong to the list of "Highest Priority Critically Important Antimicrobials"; hence, long-course penicillin V should remain as the first line antibiotic for the management of patients with streptococcal pharyngitis as far as the benefits of using these two types of antibiotics do not outweigh the harms of their unnecessary use.

AB - BACKGROUND: To evaluate the effectiveness of short courses of antibiotic therapy for patients with acute streptococcal pharyngitis.METHODS: Randomized controlled trials comparing short-course antibiotic therapy (≤5 days) with long-course antibiotic therapy (≥7 days) for patients with streptococcal pharyngitis were included. Two primary outcomes: early clinical cure and early bacterial eradication.RESULTS: Fifty randomized clinical trials were included. Overall, short-course antibiotic treatment was as effective as long-course antibiotic treatment for early clinical cure (odds ratio (OR) 0.85; 95% confidence interval (CI) 0.79 to 1.15). Subgroup analysis showed that short-course penicillin was less effective for early clinical cure (OR 0.43; 95% CI, 0.23 to 0.82) and bacteriological eradication (OR 0.34; 95% CI, 0.19 to 0.61) in comparison to long-course penicillin. Short-course macrolides were equally effective, compared to long-course penicillin. Finally, short-course cephalosporin was more effective for early clinical cure (OR 1.48; 95% CI, 1.11 to 1.96) and early microbiological cure (OR 1.60; 95% CI, 1.13 to 2.27) in comparison to long-course penicillin. In total, 1211 (17.7%) participants assigned to short-course antibiotic therapy, and 893 (12.3%) cases assigned to long-course, developed adverse events (OR 1.35; 95% CI, 1.08 to 1.68).CONCLUSIONS: Macrolides and cephalosporins belong to the list of "Highest Priority Critically Important Antimicrobials"; hence, long-course penicillin V should remain as the first line antibiotic for the management of patients with streptococcal pharyngitis as far as the benefits of using these two types of antibiotics do not outweigh the harms of their unnecessary use.

U2 - 10.3390/antibiotics9110733

DO - 10.3390/antibiotics9110733

M3 - Review

C2 - 33114471

VL - 9

JO - Antibiotics

JF - Antibiotics

SN - 2079-6382

IS - 11

M1 - 733

ER -

ID: 250812079